New research indicates that individuals who discontinue popular GLP-1 drugs like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt conventional lifestyle regimens.
Published data in a prominent health publication demonstrates that while obese individuals can lose a large proportion of their body weight while on the medication, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"People buying such drugs need to be informed of the risk of rapid rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.
That rate of regain implies a reversion to original weight in about one and a half years.
Weighing Therapies
The study, which looked at 37 of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.
Scientists emphasize that individuals who lose weight through dieting usually experience a less rapid creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Fast Regain
Doctors propose the mechanism of the injections is key to understanding the accelerated weight return.
These medications imitate a body's own chemical called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this medication means hunger is unsuppressed, making excessive eating far more likely."
An Ongoing Condition?
The NHS advise the injections for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals say that, considering the high risk of weight regain, the therapy might need to be ongoing.
This opinion is reinforced by drug manufacturers, who state that the results "underscore the chronic character of obesity," similar to managing diseases like diabetes.
User Testimonies
People who have stopped the medication report a intense resurgence of cravings.
"It felt as if a trigger flipping and you're instantly extremely hungry," said one woman.
The struggle is worsened if individuals have not developed sustainable dietary or behavioural changes during treatment.
Significant Interest
Survey data indicate that millions of people in the UK have tried these injections in the past year, with interest continuing to grow.
- Adoption is higher among females than males.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, researchers caution that while the jabs are potent tools for weight loss, they are not a standalone solution and maintained weight loss relies on combined behavioural support.